Millennium Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
Other funds holding CYTK
Millennium Management's CYTK Position: Q3 2026 in Review
Millennium Management increased its Cytokinetics (CYTK) stake by 153% in Q3 2026, buying an estimated $12.8M and bringing the position to 277,135 shares worth $18.3M. The position accounts for 0.01% of the portfolio, ranked #1704.
Millennium Management first reported a position in CYTK in Q2 2013 and has held it in 50 quarters since. The position peaked at $100M in Q4 2023. 473 funds tracked by Wall St. Rank hold CYTK as of Q3 2026.
- Millennium Management held 277,135 shares of Cytokinetics worth $18.3M as of Q3 2026.
- Millennium Management bought 167,418 Cytokinetics shares in Q3 2026, an estimated $12.8M.
- Cytokinetics made up 0.01% of Millennium Management's portfolio in Q3 2026, its #1704 holding.
- Millennium Management first reported a position in Cytokinetics in Q2 2013 and has held it in 50 quarters since.
- Millennium Management's Cytokinetics position peaked at $100M in Q4 2023.
- 473 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2026.
Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.